KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other Non-Current Liabilities (2018 - 2025)

Historic Other Non-Current Liabilities for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $741000.0.

  • Twist Bioscience's Other Non-Current Liabilities rose 8206.39% to $741000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $741000.0, marking a year-over-year increase of 8206.39%. This contributed to the annual value of $747000.0 for FY2025, which is 8353.81% up from last year.
  • According to the latest figures from Q4 2025, Twist Bioscience's Other Non-Current Liabilities is $741000.0, which was up 8206.39% from $747000.0 recorded in Q3 2025.
  • Twist Bioscience's Other Non-Current Liabilities' 5-year high stood at $28.4 million during Q4 2021, with a 5-year trough of $60000.0 in Q3 2022.
  • Over the past 5 years, Twist Bioscience's median Other Non-Current Liabilities value was $475000.0 (recorded in 2023), while the average stood at $3.1 million.
  • Per our database at Business Quant, Twist Bioscience's Other Non-Current Liabilities surged by 1340857.14% in 2021 and then tumbled by 9978.85% in 2022.
  • Over the past 5 years, Twist Bioscience's Other Non-Current Liabilities (Quarter) stood at $28.4 million in 2021, then tumbled by 99.79% to $60000.0 in 2022, then skyrocketed by 691.67% to $475000.0 in 2023, then fell by 14.32% to $407000.0 in 2024, then soared by 82.06% to $741000.0 in 2025.
  • Its Other Non-Current Liabilities was $741000.0 in Q4 2025, compared to $747000.0 in Q3 2025 and $688000.0 in Q2 2025.